| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.ASN.0000103229.25389.40 |
| P698 | PubMed publication ID | 14694159 |
| P2093 | author name string | David A Power | |
| Mark E Cooper | |||
| Vicki Levidiotis | |||
| Chris Tikellis | |||
| Craig Freeman | |||
| P433 | issue | 1 | |
| P921 | main subject | glomerulonephritis | Q605006 |
| P304 | page(s) | 68-78 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis | |
| P478 | volume | 15 |
| Q38328518 | A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer |
| Q44913115 | Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin |
| Q26747416 | Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy |
| Q55459963 | Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. |
| Q34703530 | An ELISA method for the detection and quantification of human heparanase |
| Q38936714 | Biological roles of glycans |
| Q40036696 | Cell surface-expressed cation-independent mannose 6-phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose 6-phosphate to promote extracellular matrix degradation |
| Q30495718 | Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats |
| Q34012444 | Disease-dependent mechanisms of albuminuria |
| Q34785756 | Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA |
| Q45865888 | Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats |
| Q34984825 | Effect of yiqiyangyin recipe on heparanase and nephrin in rats with adriamycin-induced nephropathy |
| Q34426913 | Elevated urine heparanase levels are associated with proteinuria and decreased renal allograft function |
| Q33775709 | Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice |
| Q34248969 | Experimental membranous nephropathy redux |
| Q38949784 | Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation |
| Q46068605 | Heparanase Inhibition Reduces Glucose Levels, Blood Pressure, and Oxidative Stress in Apolipoprotein E Knockout Mice |
| Q37413886 | Heparanase and autoimmune diabetes. |
| Q43812376 | Heparanase and macrophage interplay in the onset of liver fibrosis |
| Q28303555 | Heparanase in glomerular diseases |
| Q56894096 | Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy |
| Q54664919 | Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease. |
| Q36143598 | Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment |
| Q33834001 | Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels |
| Q38801721 | Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases |
| Q39120713 | Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease |
| Q36919158 | Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications |
| Q37611235 | Increased Granulocyte Heparanase Activity in Neutrophils from Patients with Lupus Nephritis and Idiopathic Membranous Nephropathy |
| Q79272921 | Increased expression of heparanase in overt diabetic nephropathy |
| Q37486713 | Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation |
| Q41855773 | Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. |
| Q34652072 | Mammalian heparanase: what is the message? |
| Q27312011 | Nephroprotective effect of heparanase in experimental nephrotic syndrome |
| Q36860946 | New approaches to the treatment of dense deposit disease |
| Q36118524 | New insights into the molecular biology of the glomerular filtration barrier and associated disease |
| Q43206559 | Protective effect of sulodexide on podocyte injury in adriamycin nephropathy rats |
| Q39853500 | Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species. |
| Q36101233 | Significance of heparanase in cancer and inflammation |
| Q38195528 | The endothelium in diabetic nephropathy |
| Q38156098 | The role of heparanase and the endothelial glycocalyx in the development of proteinuria |
| Q34137792 | Tumorigenic and adhesive properties of heparanase |
| Q37319738 | Where does albuminuria come from in diabetic kidney disease? |
Search more.